{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-001748","form_type":"8-K","ticker":"VACH","cik":"0002006815","company_name":"Voyager Acquisition Corp./Cayman Islands","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.974586+00:00","generated_at":"2026-05-15T23:13:46.745557+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"VERAXA shareholders approve merger with Voyager SPAC; CHF 223,400 capital increase","bullets":["Shareholders approved absorption merger of VERAXA into Veraxa Biotech Holding AG; combined entity to rename to Veraxa Biotech AG.","Approved ordinary capital increase of CHF 223,400 for shares to be issued to Voyager shareholders.","Christoph Antz remains CEO; closing subject to Voyager shareholder vote; Nasdaq ticker expected to be VRXA.","Business combination originally announced April 22, 2025; proxy statement/prospectus filed Feb 19, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-001748","json":"https://secwatch.observer/filing/0001829126-26-001748.json","markdown":"https://secwatch.observer/filing/0001829126-26-001748.md","text":"https://secwatch.observer/filing/0001829126-26-001748.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2006815/000182912626001748/0001829126-26-001748-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2006815/000182912626001748/voyageracq_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:13:46.745557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}